OVP Venture Partners
VC Fund
Seattle, United States
OVP Venture Partners is a venture capital firm specializing in early-stage technology-based companies.
- Total investments:
- 102
- Last investment:
- Lead investor:
- 33%
- Fund size:
- $250M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries OVP Venture Partners invests in
SoftwareBiotechnologyHealth CareEnterprise SoftwareSecurity
Stages OVP Venture Partners invests in
Series BSeries ASeries CFunding RoundSeries D
Countries OVP Venture Partners invests in
United StatesCanada
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Investment Focus
Industry
- Software 18 (18%)
- Biotechnology 13 (13%)
- Health Care 9 (9%)
- Enterprise Software 8 (8%)
- Security 6 (6%)
Stage
- Series B 26 (25%)
- Series A 24 (24%)
- Series C 17 (17%)
- Funding Round 11 (11%)
- Series D 6 (6%)
Country
- United States 49 (48%)
- Canada 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Gordon Steele
Board Member
|
Board Member | Total investments: 0 | Find email | |
Bill Funcannon
Controller, Managing Director & CFO
|
Controller, Managing Director & CFO | Total investments: 5 | Find email | |
Chad Waite
Managing Director
|
Managing Director | Total investments: 17 | Find email | |
|
Dick Strayer
Founder & CEO
|
Founder & CEO | Total investments: 0 | Find email | |
Gerry Langeler
Managing Director
|
Managing Director | Total investments: 15 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Founded to enable the electrification of everything - from tiny medical, consumer and commercial devices to every possible flavor and size of transportation - Group14 brings new finely-tuned performance capabilities to the era of the lithium-silicon battery. Our novel composite materials and our industrial process to make them reliably answer thecost, scale and performance barriers that have slowed the world’s transition towards the all-electric future. | $17M / Series B / Dec 21, 2020 | ||
| Founded to enable the electrification of everything - from tiny medical, consumer and commercial devices to every possible flavor and size of transportation - Group14 brings new finely-tuned performance capabilities to the era of the lithium-silicon battery. Our novel composite materials and our industrial process to make them reliably answer thecost, scale and performance barriers that have slowed the world’s transition towards the all-electric future. | $18M / Series A / Aug 09, 2019 | ||
| Verdezyne was a privately-held company that employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize commercialfermentation processes for the production of petrochemical replacements. | $48M / Mar 28, 2014 | ||
| Adapx offers software that turns natural speech, sketches, and handwriting into data for Microsoft Office and other back-end systems. By simply speaking and writing, teams get instant access to structured data collected on paper, touchscreens, mobile devices, and wall displays. A range of enterprises and agencies speed workflows and reduce risk byusing Capturx to bypass data transcription from paper and cumbersome keyboard- and menu-driven interfaces.Adapx was formerly known as Natural Interaction Systems. The company was founded in 1999 and is based in Seattle, Washington. | $3M / Apr 11, 2013 | ||
| Aggregate Knowledge (AK) is the only media intelligence company that offers advertisers and agencies an exact science to pinpoint where to reach highest performing customers in a single platform. AK’s patented media intelligence platform (MIP) is the only data management solution that combines both media and audience data, enabling marketers tomost effectively allocate media dollars, resulting in increased reach, higher sales and dramatically improved media spend efficiency. | $3.3M / Apr 01, 2013 | ||
| Aggregate Knowledge (AK) is the only media intelligence company that offers advertisers and agencies an exact science to pinpoint where to reach highest performing customers in a single platform. AK’s patented media intelligence platform (MIP) is the only data management solution that combines both media and audience data, enabling marketers tomost effectively allocate media dollars, resulting in increased reach, higher sales and dramatically improved media spend efficiency. | $11.4M / Series E / Feb 27, 2013 | ||
| EnerG2 engineers advanced nano-structured carbon materials for energy storage and is focused on the production of these materials for energy storage devices. Proprietary manufacturing technologies allow its products to surpass the material limitations of naturally occurring carbons, producing high surface area, high performance materials thatimprove power density and cycle life in batteries and other energy storage devices. EnerG2 is currently delivering its advanced carbons to customers for ultracapacitors, lead acid batteries, and lithium ion batteries. | $9.4M / Jan 12, 2013 | ||
| NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.NanoString's products are based on a novel digital molecularbarcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer. | $15.3M / Series E / Dec 03, 2012 | ||
| Adapx offers software that turns natural speech, sketches, and handwriting into data for Microsoft Office and other back-end systems. By simply speaking and writing, teams get instant access to structured data collected on paper, touchscreens, mobile devices, and wall displays. A range of enterprises and agencies speed workflows and reduce risk byusing Capturx to bypass data transcription from paper and cumbersome keyboard- and menu-driven interfaces.Adapx was formerly known as Natural Interaction Systems. The company was founded in 1999 and is based in Seattle, Washington. | $3M / Jul 30, 2012 | ||
| Symform develops cost effective solutions to large scale distributed data management problems. The Symform Cooperative Storage Cloud is a solution that combines the best practices of disaster recovery, data security and distributed networking using the power of Internet.The big idea is simple: Give local storage, get online storage. Memberscontribute unused server space equal to the amount they consume in the storage cloud. Symform handles the day-to-day management of network security and administration of the storage cloud. | $11M / Series B / Apr 25, 2012 | ||
| See all 102 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Enterprise Software Investors
13,836 investors
SaaS VC Funds
61,208 investors
Enterprise VC Funds
49,693 investors
FAQ
What does OVP Venture Partners invest in?
OVP Venture Partners invests primarily in Software, Biotechnology and Health Care startups, most often at Series B and Series A stage. Most of the 102 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact OVP Venture Partners?
Public channels for OVP Venture Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at OVP Venture Partners?
The team at OVP Venture Partners includes Gordon Steele (Board Member), Bill Funcannon (Controller, Managing Director & CFO) and Chad Waite (Managing Director), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
